New Podcast Episode: The Reality of Medicare's 2026 Drug Price Negotiations
This year, Medicare's newly negotiated prices for 10 common, high-cost drugs (including Eliquis, Xarelto, and Jardiance) have officially rolled out. However, recent polls show that only 38% of voters ages 65 and older are even aware that these negotiations took place.
More importantly, the impact on your wallet might not be what you expect. While the negotiations were designed to bring financial relief, some beneficiaries are finding that their Part D plans are responding by raising prices for these specific medications or removing them from their formularies altogethe.
In our newest podcast episode, we break down exactly what is happening in the market, which of the 10 drugs are affected, and what you need to watch out for.
👉 Click here to listen and stay informed: https://creators.spotify.com/pod/profile/renea-griffith-stasaski/episodes/Historic-Drug-Price-Negotiations-Finally-Take-Effect-e3gvcb9
11 views
No comments